Cigarette smoking is the leading preventable cause of morbidity and mortality among women in the US. quitting smoking may be especially problematic for women. Yoga is an ancient, multi-component system consisting of both mental and physical practices or """"""""Sudras"""""""". As a form of exercise, yoga shares many of the same properties as traditional (Western) aerobic exercise which our previous research has shown to be an efficacious adjunct to smoking cessation treatment. Yoga may also offer other benefits that may make it an especially effective complimentary treatment for women who are attempting to quit smoking. ? ? In this study we will recruit two cohorts of 30 women smokers and provide cognitive-behavioral therapy for smoking cessation once weekly for 12 weeks. In addition, participants will be randomly assigned them to receive either; (1) Yoga or (2) a Wellness program (contact-control), twice weekly during the 12 week program. All participants will be assessed for changes in smoking behavior, psychosocial variables relevant to smoking cessation, exercise adoption, and other psychological constructs that may act as mechanisms of action (mediators) of yoga and smoking cessation. These variables include; weight concerns, perceived stress, mindfulness, self-esteem, quality of life and group cohesion. Group interviews will be used to collect qualitative data at the end of each cohort. The proposed study is designed to provide key data necessary to establish several research fundamentals necessary to support a full scale efficacy trial. These include: 1) establishing intervention feasibility and acceptability in the target population, 2) piloting recruitment and retention procedures and identifying barriers to participation, 3) obtaining qualitative feedback from participants to enhance treatment content and/or design, 4) establishing anticipated effect size estimates, and 5) identifying likely mechanisms of action (mediators) that may be responsible for intervention efficacy. This application responds to a program announcement (PAR-03-153) from the National Center for Complimentary and Alternative Medicine (NCCAM): exploratory/developmental grants for clinical studies. The proposed study is designed to provide key data necessary to establish these research fundamentals. These include: establishing intervention feasibility, anticipated effect size estimates, and identifying likely mechanisms of action (mediators) that may be responsible for intervention efficacy. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AT003669-02
Application #
7408517
Study Section
Special Emphasis Panel (ZAT1-JH (18))
Program Officer
Alekel, D Lee
Project Start
2007-08-01
Project End
2011-07-31
Budget Start
2008-08-01
Budget End
2011-07-31
Support Year
2
Fiscal Year
2008
Total Cost
$277,688
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Thind, Herpreet; Jennings, Ernestine; Fava, Joseph L et al. (2016) Differences between Men and Women Enrolling in Smoking Cessation Programs Using Yoga as a Complementary Therapy. J Yoga Phys Ther 6:
Rosen, Rochelle K; Thind, Herpreet; Jennings, Ernestine et al. (2016) ""Smoking Does Not Go With Yoga:"" A Qualitative Study of Women's Phenomenological Perceptions During Yoga and Smoking Cessation. Int J Yoga Therap 26:33-41
Gaskins, Ronnesia B; Jennings, Ernestine G; Thind, Herpreet et al. (2015) Recruitment and initial interest of men in yoga for smoking cessation: QuitStrong, a randomized control pilot study. Transl Behav Med 5:177-88
Bock, Beth C; Fava, Joseph L; Gaskins, Ronnesia et al. (2012) Yoga as a complementary treatment for smoking cessation in women. J Womens Health (Larchmt) 21:240-8
Bock, Beth C; Morrow, Kathleen M; Becker, Bruce M et al. (2010) Yoga as a complementary treatment for smoking cessation: rationale, study design and participant characteristics of the Quitting-in-Balance study. BMC Complement Altern Med 10:14